BioCryst Pharmaceuticals
- Biological Products, Except Diagnostic Substances
- Durham, North Carolina
Compensation history
Top executives at BioCryst Pharmaceuticals received an average of $2M per person in annual compensation from 2006 to 2021.
By year
- 2021
MS$8MMegan T. SniecinskiFormer Chief Business OfficerJS$7MJon P. StonehousePresident, Chief Executive Officer and DirectorHT$7MHelen M. ThackrayChief R&D OfficerAD$3MAnthony J. DoyleChief Financial OfficerWS$3MWilliam P. SheridanChief Medical OfficerYB$2MYarlagadda S. BabuChief Discovery Officer- 2019
JS$2MJon P. StonehousePresident, Chief Executive Officer and DirectorMS$2MMegan T. SniecinskiSenior Vice President and Chief Business OfficerYB$1MYarlagadda S. BabuSenior Vice President of Drug DiscoveryWS$1MWilliam P. SheridanSenior Vice President and Chief Medical OfficerTS$910KThomas R. Staab IISenior Vice President and Chief Financial Officer
Executives
We found 17 executives who work or worked at BioCryst Pharmaceuticals.
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
Anthony Doyle
BioCryst Pharmaceuticals
Chief Financial Officer
Helen Thackray
BioCryst Pharmaceuticals
Chief R&D Officer
Yarlagadda Babu
BioCryst Pharmaceuticals
Chief Discovery Officer
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
Megan Sniecinski
BioCryst Pharmaceuticals
Former Chief Business Officer
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
Lynne Powell
BioCryst Pharmaceuticals
Senior Vice President and Chief Commercial Officer
News
About BioCryst Pharmaceuticals
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Biological Products, Except Diagnostic Substances
- 4505 Emperor Boulevard, Suite 200, Durham, North Carolina 27703
- 919-859-1302
- December 31